论文部分内容阅读
Background Compliance rate of blood lipids are not satisfied when we used only statin therapy,we deserve the influence of the rosuvastatin combined with ezetimibe to glucose and lipid metabolism of the patients with acute coronary syndrome and impaired glucose regulation.